Zhitong Finance App News, China Resources Shuanghe (600062.SH) issued an announcement. Recently, China Resources Zizhu Pharmaceutical Co., Ltd. (“China Resources Zizhu”), a wholly-owned subsidiary of the company, received the “Drug Supplement Application Approval Notice” for propranolol hydrochloride injections issued by the State Drug Administration. After review, a supplementary application for adding the 2ml:2mg specification to this product was approved, and a drug approval number was issued. This product passed the consistent evaluation of the quality and efficacy of generic drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.